View in EDS HTML Full Text PDF Full Text

Immunogenicity assessment for vidutolimod: a risk-driven approach for a simplified 1-tiered, singlicate anti-drug antibody testing strategy.

Saved in:
Bibliographic Details
Title: Immunogenicity assessment for vidutolimod: a risk-driven approach for a simplified 1-tiered, singlicate anti-drug antibody testing strategy.
Authors: Valentine JL; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States., Shank S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States., Fred Lucena LM; Immunologix Laboratories, Tampa, FL, United States., Wang Z; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States., Stern CM; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States., Kim BC; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States., Lu K; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States., Prabhu S; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States., Partridge MA; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States.
Source: Frontiers in immunology [Front Immunol] 2026 May 19; Vol. 17, pp. 1751717. Date of Electronic Publication: 2026 May 19 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 42238586
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Immunogenicity assessment for vidutolimod: a risk-driven approach for a simplified 1-tiered, singlicate anti-drug antibody testing strategy.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Valentine+JL%22">Valentine JL</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Shank+S%22">Shank S</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Fred+Lucena+LM%22">Fred Lucena LM</searchLink>; Immunologix Laboratories, Tampa, FL, United States.<br /><searchLink fieldCode="AU" term="%22Wang+Z%22">Wang Z</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Stern+CM%22">Stern CM</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Kim+BC%22">Kim BC</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Lu+K%22">Lu K</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Prabhu+S%22">Prabhu S</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States.<br /><searchLink fieldCode="AU" term="%22Partridge+MA%22">Partridge MA</searchLink>; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2026 May 19; Vol. 17, pp. 1751717. <i>Date of Electronic Publication: </i>2026 May 19 (<i>Print Publication: </i>2026).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42238586
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2026.1751717
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1751717
    Titles:
      – TitleFull: Immunogenicity assessment for vidutolimod: a risk-driven approach for a simplified 1-tiered, singlicate anti-drug antibody testing strategy.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Valentine JL
      – PersonEntity:
          Name:
            NameFull: Shank S
      – PersonEntity:
          Name:
            NameFull: Fred Lucena LM
      – PersonEntity:
          Name:
            NameFull: Wang Z
      – PersonEntity:
          Name:
            NameFull: Stern CM
      – PersonEntity:
          Name:
            NameFull: Kim BC
      – PersonEntity:
          Name:
            NameFull: Lu K
      – PersonEntity:
          Name:
            NameFull: Prabhu S
      – PersonEntity:
          Name:
            NameFull: Partridge MA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 19
              M: 05
              Text: 2026 May 19
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 17
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1